What’s next in the race for a coronavirus treatment

Drugmaker Gilead is set to release clinical trial data in the next couple of weeks for a potential coronavirus treatment — the next big benchmark in a breakneck race to develop a drug that will help arrest the global pandemic.

Why it matters: The only way to truly get back to normal is through a treatment or, ideally, a vaccine. And the World Health Organization has said Gilead’s drug, called remdesivir, is the “most promising candidate.”

What we’re watching: Gilead’s next data release will come from a clinical trial being conducted in China. There’s some concern that the trial isn’t as strong as researchers had hoped, but Gilead seems to be expecting good things. It has ramped up production and supply.

What’s next: Several other drugs are in late-stage trials. Those are by far the closest to mass production, but the biggest hope rests with a vaccine.

Συνέχεια ανάγνωσης εδώ

Πηγή: axios.com